Day: November 12, 2025

Taseko Announces Improved Third Quarter Financial and Operational Results

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

Total Operating (C1) Costs* (US$ per pound)Total Operating (C1) Costs* (US$ per pound)VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) — Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the “Company”) reports third quarter 2025 Adjusted EBITDA* of $62 million, a net loss of $28 million ($0.09 per share) and Adjusted net income* of $6 million ($0.02 earnings per share). Revenues for the third quarter were $174 million from the sale of 26 million pounds of copper and 421 thousand pounds of molybdenum. Gibraltar copper production significantly improved over the previous two quarters as mining continued to advance deeper into higher grade ore in the Connector pit. In the third quarter, Gibraltar produced 27.6 million pounds of copper, which includes 895 thousand...

Kneat Announces Record Revenue for Third Quarter 2025

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

SaaS Revenue Growth Accelerates to 33% Year over Year LIMERICK, Ireland, Nov. 12, 2025 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three-month period ended September 30, 2025. All dollar amounts are presented in Canadian dollars unless otherwise stated.Third-quarter 2025 total revenue reaches $16.1 million, an increase of 26% year over year Third-quarter SaaS revenue reached $15.2 million, an increase of 33% year over year Third-quarter gross profit reaches $12.2 million, an increase of 25% year over year Gross margin for the quarter ended September 30, 2025 reaches 76% Annual Recurring Revenue (ARR)1 at September 30, 2025, grows 37% year over year to $68.6 million.“This...

Clairvest Reports Fiscal 2026 Second Quarter Results

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2026 second quarter and six months ended September 30, 2025. (All figures are in Canadian dollars unless otherwise stated) HighlightsSeptember 30, 2025 book value was $1,154 million or $83.92 per share compared with $1,260 million or $88.94 per share as at June 30, 2025. Net loss for the quarter ended September 30, 2025 was $76.8 million or $5.43 per share. The net loss for the quarter was primarily due to the full provision of Clairvest’s investment in Head Digital Works, which experienced a material adverse regulatory development in its operations in India. As at June 30, 2025, Clairvest’s investment in Head Digital Works had a $121 million carrying value. The write-off generated a loss of $8.55 per share on a pre-tax,...

Bird Reports 2025 Third Quarter Results; Record $10 Billion Combined Backlog and Pending Backlog

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

MISSISSAUGA, Ontario, Nov. 12, 2025 (GLOBE NEWSWIRE) — “Sustained demand in Bird’s key strategic sectors, along with the Company’s proven track record in delivering complex institutional, industrial and infrastructure projects, helped drive Bird’s combined Backlog and Pending Backlog to over $10.0 billion at September 30, 2025. Continuing to reflect favourable margins to a year ago, the combination of Backlog and Pending Backlog give Bird line of sight into future revenue growth and margin accretion and further conviction in achieving our 2027 strategic targets.” stated Teri McKibbon, President and CEO of Bird Construction. “Bird’s extensive self-perform capabilities, bolstered by strategic acquisitions such as the recently completed acquisition of Fraser River Pile & Dredge, have positioned the Company to pursue and win work...

Element Reports Record Quarterly Results for Q3 2025

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

Amounts in US$ unless otherwise noted Net revenues increased by 10% year-over-year, reflecting strong performance across all components Adjusted operating expenses1,2 in Q3 2025 rose 9% year-over-year, resulting in positive operating leverage of +0.7% and an adjusted operating margin of 58% Q3 2025 adjusted diluted EPS2 increased 14% to $0.33 year-over-year, underpinned by solid operational execution Strong cash generation drove adjusted2 diluted free cash flow per share up 17% to $0.42, while adjusted2 return on equity expanded to 18.8%, up 190 basis points from Q3 2024 Client originations remained solid at $1.7 billion in Q3 2025, led by record volume in Mexico, and vehicles under management (“VUM”) increased 2% year-over-year to 1.53 million Repurchased...

Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance

Written by Customer Service on November 12, 2025. Posted in Public Companies.

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine)Demonstrates PCR-corrected cure rate of 97.4% based on estimand method, equating to 99.2% under conventional per protocol analysisIf approved, GanLum would represent first major innovation in malaria treatment since 1999, with potential to kill drug-resistant parasites and block transmissionNovel ingredient in GanLum, ganaplacide, has entirely new mechanism of action, discovered after screening 2.3 million moleculesHighlights Novartis long-term commitment to combating malaria, with more than 1.1 billion treatment courses of Coartem provided largely at no profit, and multiple novel antimalarial compounds in developmentBasel, November 12, 2025 – Novartis today announced...

TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026

Written by Customer Service on November 12, 2025. Posted in Public Companies.

America’s Growth LeadersCytek Biosciences has been recognized by TIME as one of America’s Growth Leaders of 2026. Presented in partnership with global data firm Statista, the ranking recognizes the top-performing publicly listed companies in the United States that have demonstrated exceptional growth, financial stability, and stock performance over the past five years.FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the top-performing publicly listed companies in the United States that have demonstrated exceptional growth, financial stability, and stock performance over the past...

OTC Markets Group Reports Third Quarter 2025 Financial Results Delivering Strong Revenue, Operating Income, and Earnings Growth

Written by Customer Service on November 12, 2025. Posted in Public Companies.

Third Quarter 2025 Highlights:Gross revenues of $31.6 million for the quarter, up 15% versus the prior year period Operating income of $10.6 million for the quarter, up 23% versus the prior year period Operating profit margin of 34.6%, versus 32.4% for the prior year period Net income of $8.6 million, up 15% versus the prior year period, and quarterly diluted GAAP EPS of $0.71, up 16% Total cash returned to shareholders during the quarter of $2.2 million, in the form of dividends Announcing special dividend of $1.75 per share and fourth quarter 2025 dividend of $0.18 per share 553 OTCQX® and 1,097 OTCQB® companies at quarter end 19 graduates to a national securities exchange during the quarter 114 subscribers to OTC Link ECN as of September 30, 2025, unchanged from September 30, 2024 138 unique OTC Link subscribers as of September 30,...

iAnthus Reports Third Quarter 2025 Financial Results

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

NEW YORK and TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the third quarter ended September 30, 2025. The Company’s Quarterly Report on Form 10-Q (the “Quarterly Report”), which includes its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2025 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, on the System for Electronic Document Analysis and Retrieval’s (SEDAR+) website at www.sedarplus.com, and on...

Aeluma Announces First Quarter Fiscal 2026 Financial Results

Written by Customer Service on November 12, 2025. Posted in Earnings Releases And Operating Results.

Execution on Strategic Priorities Positions Aeluma for Future Growth GOLETA, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its first quarter of fiscal 2026 ended September 30, 2025. Management Commentary “We had another strong quarter executing on our strategic priorities including bolstering our balance sheet with a capital raise to accelerate growth, adding key talent throughout the organization, increasing our manufacturing readiness, and advancing towards commercialization,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “In this quarter, we also initiated a new contract with NASA, met several milestones for existing contracts, and...

Day: November 12, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals